Comparison of EQ-5D-3L and 5L versions following operative fixation of closed ankle fractures.


Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
Jul 2022
Historique:
accepted: 05 02 2022
pubmed: 20 2 2022
medline: 15 6 2022
entrez: 19 2 2022
Statut: ppublish

Résumé

To undertake the first testing and comparison of measurement properties for the EuroQol EQ-5D-3L and 5L in patients with ankle problems. The cross-sectional postal survey of 959 patients aged ≥ 18 years, who underwent surgical treatment (ORIF) for unstable and closed ankle fractures in Eastern Norway. Both the EQ-5D-3L and 5L were included in a postal questionnaire in 2015, 3-6 years post surgery. Missing data, floor and ceiling effects, and response consistency were assessed. Tests of validity included comparisons with scores for the SF-36 and widely used ankle-specific instruments. The 5L version was assessed for test-retest reliability. There were 567 (59%) respondents; 501 completed both versions and 182 (61%) the 5L retest questionnaire. The 5L outperformed the 3L in tests of data quality and classification efficiency. Correlations with scores for other instruments largely met expectations, those for the 5L being slightly higher. All 5L scores had acceptable levels of reliability. For the 5L index, the smallest detectable differences for group and individual comparisons were 0.02 and 0.20, respectively. The 5L outperformed the 3L in terms of data quality, number of health states assessed and tests of validity. The 5L is recommended in research and other applications following surgery for ankle fracture but further testing including responsiveness to change is recommended at clinically relevant follow-up periods.

Identifiants

pubmed: 35182304
doi: 10.1007/s11136-022-03105-2
pii: 10.1007/s11136-022-03105-2
pmc: PMC9188494
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2071-2082

Subventions

Organisme : Norges Forskningsråd
ID : 262673

Informations de copyright

© 2022. The Author(s).

Références

Qual Life Res. 2021 Oct;30(10):2729-2754
pubmed: 34247326
Patient. 2019 Aug;12(4):383-392
pubmed: 30607809
Qual Life Res. 2010 May;19(4):539-49
pubmed: 20169472
Acta Orthop. 2007 Oct;78(5):584-91
pubmed: 17966016
Qual Life Res. 2022 Feb;31(2):517-526
pubmed: 34272631
Popul Health Metr. 2018 Aug 16;16(1):14
pubmed: 30115092
Eur Spine J. 2005 Dec;14(10):1000-7
pubmed: 15843969
Injury. 2016 Jul;47(7):1514-8
pubmed: 27173090
Pharmacoeconomics. 2018 Jun;36(6):675-697
pubmed: 29470821
Injury. 2017 Jul;48(7):1662-1669
pubmed: 28392074
BMJ. 2002 Jun 15;324(7351):1417
pubmed: 12065262
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Qual Life Res. 2019 Jan;28(1):153-162
pubmed: 30317426
Clin Orthop Relat Res. 2019 Jul;477(7):1645-1647
pubmed: 31206412
Qual Life Res. 2021 Mar;30(3):841-854
pubmed: 32930993
Eur J Health Econ. 2021 Jun;22(4):621-628
pubmed: 33733344
Qual Life Res. 2021 Mar;30(3):855-866
pubmed: 32965633
Trials. 2018 May 31;19(1):304
pubmed: 29855386
Clin Orthop Relat Res. 2019 Jul;477(7):1632-1644
pubmed: 30801280
Acta Orthop. 2014 Apr;85(2):187-94
pubmed: 24564747
BMC Musculoskelet Disord. 2018 May 2;19(1):134
pubmed: 29720142
Qual Life Res. 2019 Jan;28(1):141-152
pubmed: 30225788
J Clin Epidemiol. 2018 Oct;102:23-37
pubmed: 29793009
Qual Life Res. 2019 Sep;28(9):2409-2417
pubmed: 31089988
Value Health. 2012 Jul-Aug;15(5):708-15
pubmed: 22867780
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
J Intern Med. 2016 Feb;279(2):141-53
pubmed: 26306802
Health Qual Life Outcomes. 2017 Mar 14;15(1):51
pubmed: 28292292
J Bone Joint Surg Br. 2012 Feb;94(2):215-21
pubmed: 22323689
Pharmacoeconomics. 2018 Jun;36(6):645-661
pubmed: 29572719
Appl Health Econ Health Policy. 2017 Apr;15(2):127-137
pubmed: 28194657
Health Qual Life Outcomes. 2020 Sep 29;18(1):317
pubmed: 32993637
Qual Life Res. 2021 May;30(5):1477-1490
pubmed: 33534032
Arch Orthop Trauma Surg (1978). 1984;103(3):190-4
pubmed: 6437370
Phys Ther. 1999 Apr;79(4):371-83
pubmed: 10201543
Med Care. 1997 Nov;35(11):1095-108
pubmed: 9366889
Qual Life Res. 2018 May;27(5):1147-1157
pubmed: 29435801
J Foot Ankle Surg. 2016 Nov - Dec;55(6):1195-1198
pubmed: 27614825

Auteurs

Andrew Garratt (A)

Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway. andrew.garratt@fhi.no.

Knut Stavem (K)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Pulmonary Medicine, Medical Division, Akershus University Hospital, Lørenskog, Norway.
Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH